S&P 500   4,551.68 (-0.51%)
DOW   35,490.69 (-0.74%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
S&P 500   4,551.68 (-0.51%)
DOW   35,490.69 (-0.74%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
S&P 500   4,551.68 (-0.51%)
DOW   35,490.69 (-0.74%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
S&P 500   4,551.68 (-0.51%)
DOW   35,490.69 (-0.74%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
NYSE:NHI

National Health Investors Stock Forecast, Price & News

$57.10
+0.70 (+1.24 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$56.28
$57.31
50-Day Range
$52.51
$62.95
52-Week Range
$51.78
$78.56
Volume
223,523 shs
Average Volume
308,384 shs
Market Capitalization
$2.62 billion
P/E Ratio
16.74
Dividend Yield
6.38%
Beta
0.91
30 days | 90 days | 365 days | Advanced Chart
Receive NHI News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.


National Health Investors logo

About National Health Investors

National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
63633D10
Employees
20
Year Founded
1991

Sales & Book Value

Annual Sales
$332.81 million
Cash Flow
$5.99 per share
Book Value
$34.05 per share

Profitability

Net Income
$185.13 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$2.62 billion
Next Earnings Date
11/8/2021 (Confirmed)
Fiscal Year End
N/A
Optionable
Optionable

Social Links


MarketRank

Overall MarketRank

2.62 out of 5 stars

Finance Sector

163rd out of 1,335 stocks

Real Estate Investment Trusts Industry

29th out of 220 stocks

Analyst Opinion: 1.9Community Rank: 3.9Dividend Strength: 3.3Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -












National Health Investors (NYSE:NHI) Frequently Asked Questions

Is National Health Investors a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating and 7 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" National Health Investors stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View analyst ratings for National Health Investors
or view top-rated stocks.

What stocks does MarketBeat like better than National Health Investors?

Wall Street analysts have given National Health Investors a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but National Health Investors wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is National Health Investors' next earnings date?

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for National Health Investors
.

How can I listen to National Health Investors' earnings call?

National Health Investors will be holding an earnings conference call on Monday, November 8th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) posted its quarterly earnings results on Monday, August, 9th. The real estate investment trust reported $0.85 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by $0.40. The real estate investment trust earned $74.33 million during the quarter, compared to analyst estimates of $77.22 million. National Health Investors had a net margin of 48.09% and a trailing twelve-month return on equity of 10.04%. The company's quarterly revenue was down 11.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.46 earnings per share.
View National Health Investors' earnings history
.

How has National Health Investors' stock price been impacted by COVID-19?

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NHI stock has decreased by 19.4% and is now trading at $57.10.
View which stocks have been most impacted by COVID-19
.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors declared a quarterly dividend on Monday, August 9th. Shareholders of record on Thursday, September 30th will be given a dividend of $0.90 per share on Friday, November 5th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 6.30%. The ex-dividend date of this dividend is Wednesday, September 29th.
View National Health Investors' dividend history
.

Is National Health Investors a good dividend stock?

National Health Investors pays an annual dividend of $3.60 per share and currently has a dividend yield of 6.38%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of National Health Investors is 64.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, National Health Investors will have a dividend payout ratio of 67.92% next year. This indicates that National Health Investors will be able to sustain or increase its dividend.
View National Health Investors' dividend history.

What price target have analysts set for NHI?

8 analysts have issued 1 year target prices for National Health Investors' stock. Their forecasts range from $55.00 to $77.00. On average, they expect National Health Investors' stock price to reach $67.17 in the next twelve months. This suggests a possible upside of 17.6% from the stock's current price.
View analysts' price targets for National Health Investors
or view top-rated stocks among Wall Street analysts.

Who are National Health Investors' key executives?

National Health Investors' management team includes the following people:
  • D. Eric Mendelsohn, President, Chief Executive Officer & Director
  • John L. Spaid, Chief Financial Officer & Executive VP-Finance
  • David Louis Travis, Chief Accounting Officer & Senior Vice President
  • Kevin C. Pascoe, Chief Investment Officer
  • Kristin Sallee Gaines, Chief Credit Officer

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by many different institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (1.11%), Strs Ohio (0.13%), Nepsis Inc. (0.10%), State of New Jersey Common Pension Fund D (0.10%), Shilanski & Associates Inc. (0.10%) and Sound Income Strategies LLC (0.06%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors
.

Which institutional investors are selling National Health Investors stock?

NHI stock was sold by a variety of institutional investors in the last quarter, including Gradient Investments LLC, Sound Income Strategies LLC, and Strs Ohio.
View insider buying and selling activity for National Health Investors
or view top insider-selling stocks.

Which institutional investors are buying National Health Investors stock?

NHI stock was bought by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Nepsis Inc., State of New Jersey Common Pension Fund D, Sumitomo Mitsui DS Asset Management Company Ltd, Shilanski & Associates Inc., State of Alaska Department of Revenue, Pensionfund Sabic, and Stephens Inc. AR. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors
or or view top insider-buying stocks.

How do I buy shares of National Health Investors?

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $57.10.

How much money does National Health Investors make?

National Health Investors has a market capitalization of $2.62 billion and generates $332.81 million in revenue each year. The real estate investment trust earns $185.13 million in net income (profit) each year or $5.60 on an earnings per share basis.

How many employees does National Health Investors have?

National Health Investors employs 20 workers across the globe.

When was National Health Investors founded?

National Health Investors was founded in 1991.

What is National Health Investors' official website?

The official website for National Health Investors is www.nhireit.com.

Where are National Health Investors' headquarters?

National Health Investors is headquartered at 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at (615) 890-9100 or via email at [email protected].


This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.